Region:
UK
Edition:
MPS Allocators
- 2025 Q3

We are inclined to believe that a correction may occur in the coming months as global equity market valuations are once again elevated and not pricing in several of the key risks that we see. These include escalating tensions in Iran, the end of the tariff pause, and the passing of the US budget bill. All could have negative implications for global growth, inflation and therefore result in earnings revisions.

We remain cautious and are underweight equities for the time being. However, we are still broadly optimistic that good risk adjusted returns can be made in multi asset portfolios before year end. We will use any weakness in markets to top up our European equity allocation.

Explore the different Outlooks

Chris Robinson
Dan Appleby
David Hood
Dr Bevan Blair
Edward Lloyd
Eren Osman
James Burns
Julian Menges
Liam Goodbrand
Matthew Hinman
Phil Wellington
Raj Manon
Raymond Backreedy
Richard Bonnor-Moris
Robert Hale
Ross McKnight
Saftar Sarwar
Simon Doherty
Stacey Ash
Tom McGrath
No items found.